Resultados de la búsqueda 201-210 of 9505 for Assay

  1. Medicina cardiovascular - Ensayos clínicos

    Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

  2. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Laboratory Assay Optimization 2.0. Rochester, Minn. The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 ...

  3. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  5. Medicina cardiovascular - Ensayos clínicos

    Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

  6. Oncología (médica) - Ensayos clínicos

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  7. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    Laboratory Assay Optimization 2.0. Rochester, Minn. The purpose of this study is to better understand the role of HIV and/or HCV infection and/or SARS-CoV-2 ...

  8. Oncología (médica) - Ensayos clínicos

    Circulating Tumor DNA (cTDNA) Based in NGS (Next Generation Sequencing) Assays for Oncology Patients With Solid Tumors ... assays and results from a ctDNA assay ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...